Skip to content
In a development hailed as a possible cancer breakthrough, Moderna announced Tuesday that its experimental personalized cancer vaccine, employing the mRNA technology the company developed […]
Moderna’s personalized mRNA melanoma vaccine achieves positive results Read More »
When nurse Sandra Lindsay received the first dose of the COVID-19 vaccine in the United States outside of a clinical trial on this day
COVID-19 vaccines two years later: 3 million lives and a trillion dollars saved Read More »
The lack of gender and racial diversity in medical R&D in the United States is ever-present and persistent, including in trials for COVID-19 medicines
Data shows persistent inequities in U.S. COVID treatment trials, rare disease R&D Read More »
Common bacterial infections are becoming increasingly resistant to antibiotics, “causing life-threatening bloodstream infections,” a new World Health Organization (WHO) report warns. Based on “data
WHO report warns of the rise in antibiotic resistance, seeks better data Read More »
Takeda announced the European Commission (EC) authorized the company’s new dengue vaccine for people aged 4 and up. The European Union approved the two-dose
Takeda’s dengue vaccine approved for use in the EU Read More »
Could the Office of the U.S. Trade Representative’s (USTR) position on the COVID IP waiver be shifting? On December 6, USTR announced support for “extending
U.S. punts decision on COVID IP waiver to 2023 Read More »
The Centers for Disease Control and Prevention (CDC) has released new data demonstrating how the updated (bivalent) boosters effectively enhance COVID-19 protection. “[B]ivalent boosters
Bivalent COVID boosters are available – here’s why you should get one Read More »
Dobbs v. Jackson has had a ripple effect across healthcare—from increasing the danger of medical management of miscarriages and risk of maternal mortality, to
How Dobbs v. Jackson is affecting vaccine innovation Read More »
Positive results in trials of cancer treatments were announced by the biotech firms Nkarta and Novartis this week. Nkarta trial shows benefits of ‘natural
Nkarta, Novartis announce positive data in cancer treatment trials Read More »
“The pandemic has exposed our country’s dependence on other countries for essential prescription drugs,” began Steve Scully, contributing editor at The Hill and moderator
COVID-19 forced us to reimagine the pharma supply chain – and that’s a good thing Read More »
